Cashin Richard M Jr's Form 4 filing
AdaptHealth Corp. (AHCO) · filed Mar 12, 2026
- Accession no.
- 0001193125-26-104760
- Filed
- Mar 12, 2026
- Trade date
- Mar 10-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $19.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cashin Richard M JrCIK 0001172898 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Common Stock | PPurchaseAcquired | +820,528 | $9.73F1 | +$7,983,737.44 | 14,638,708 | Indirect | |
| Mar 11, 2026 | Common Stock | PPurchaseAcquired | +536,827 | $9.73F4 | +$5,223,326.71 | 15,175,535 | Indirect | |
| Mar 12, 2026 | Common Stock | PPurchaseAcquired | +689,336 | $9.73F5 | +$6,707,239.28 | 15,864,871 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.58 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.64 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
EDGAR filing codes for Investor, the Parallel Funds, OEP VII GP, OEP VII GP LLC (collectively, the "OEP Entities") were not accessible at the time of this filing but, as direct and indirect holders of the reported securities, are intended and deemed to be included as reporting persons on this Form 4. When such EDGAR filing codes are received from the Securities and Exchange Commission, this Form 4 will be amended to reflect the OEP Entities as reporting persons.